Outcomes from an extended scope of practice speech-language pathology service for low risk ENT outpatients: A 5-year service review.
Maria SchwarzElizabeth C WardMarnie SeabrookJennifer DavisBernard C S WhitfieldPublished in: International journal of speech-language pathology (2021)
Purpose: Early evidence supports the safety and efficiency of extended scope speech-language pathology (SLP) clinics designed to manage low risk ear nose and throat (ENT) outpatient referrals, however long-term data is lacking. The aim of this study was to complete a 5-year audit of clinical outcomes, including rates of re-referral, for a SLP Allied Health Practitioner (SLP AHP) led dysphagia and dysphonia service within an Integrated Specialist ENT Service.Method: A retrospective audit was undertaken of all patients referred with non-urgent dysphonia and/or dysphagia symptoms over a 5-year period since establishment of the SLP AHP service. Clinical outcomes, rates and reasons for re-referral to the specialist ENT waiting list were investigated.Result: Of 616 patient referrals, 462 patients were seen by the SLP AHP service. Most (72%, n = 333) received all required management through the clinical model, with only 28% (n = 129) requiring additional ENT intervention, consistent with previously published data. Only 36 of the 616 (6%) were re-referred/re-presented within 12 months of first presentation, of which only 12 were referred for same condition as initial referral. No adverse outcomes were recorded on the clinical database during this 5-year period.Conclusion: Results provide further evidence that the SLP AHP service is a safe and efficient method for managing low risk ENT outpatient referrals.
Keyphrases
- mental health
- healthcare
- primary care
- end stage renal disease
- ejection fraction
- newly diagnosed
- randomized controlled trial
- chronic kidney disease
- autism spectrum disorder
- palliative care
- public health
- peritoneal dialysis
- electronic health record
- patient reported
- risk assessment
- climate change
- big data
- mass spectrometry
- adverse drug
- health information
- social media
- health promotion